
Understanding which antigens are targetable in a tumor forms the basis for personalized immunotherarapies, which just got a big boost from the recent announcement by @moderna_tx at @myESMO. We are excited to share a timely perspective on this topic with @TheVinodLab & Zach Sethna the Olayan Center for Cancer Vaccines @MSKCancerCenter out now in @Cancer_Cell. We discuss the theoretical basis of neoantigen quality, which alterations in a tumor the immune system targets, within the theory of what is nonself. This topic has been one of discussion for us for over a decade. Several paradoxes emerge, in particular, that viruses inhabit spaces close to self. So the immune system likely surveils close to self antigens, like we see in cancer, in order to fight viruses which exert strong evolutionary pressure (shout out to @JonAvramLevine & @andimscience). A model which captures one can therefore inform the other. Lots of work to do! Enjoy the work below 👇👇👇 sciencedirect.com/science/ar… PS - If you like science of this sort and are looking for a postdoc consider our Theory Group effort at @MSKCancerCenter: careers.mskcc.org/vacancies/…


